1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-X0033C |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | Lymphocytes |
Shipping Info | Dry Ice |
Growth Conditions | 37 °C, 5% CO2 |
Source Organ | Lymphatic |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Overexpression Stable Cell Lines |
Host Cell | BAF3 |
The BCR ABL (V468F) BAF3 Cell Line harbors a V468F mutation within the ABL kinase domain, expressed via lentiviral transduction in BAF3 cells. This mutation alters the ATP-binding pocket, contributing to resistance to first-line tyrosine kinase inhibitors. Validation includes qRT-PCR and sequencing.
Target
BCR-ABL V468F mutation enhances oncogenic signaling and is associated with resistance to imatinib. This model enables the evaluation of second- and third-generation TKIs in TKI-resistant CML. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
For research use only